EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages

Katie J Suda, Xinhua Zhao, Sherrie L Aspinall iD, Yaming Li, Katherine Callaway Kim, Francesca E Cunningham, Taylor L Boyer iD, Tate W Miner, Clara Kima, Walid F Gellad iD, Peter A Glassman, Chester B Good iD und 3 weitere

Pharmacoepidemiology and Drug Safety · 2026-06 · 35 (6)

DOI: 10.1002/pds.70393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 19.05.2026. Verfasst von Katie J Suda und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Veterans, Drug Monitoring, Prescription Drugs. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HSRD VA, U.S. Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although drug shortages for outpatient chronic conditions commonly occur, population‐level data on how they impact patients' ability to refill prescriptions is scarce. We sought to identify distinct patterns of refill adherence following drug shortages and patient‐ and prescription‐level factors associated with adherence trajectories reflecting potential shortage‐related treatment disruption.

Methods

We retrospectively analyzed panel data assembled from 2017 to 2020 Veterans Health Administration (VHA) electronic health record data. Patients were included if they were baseline users of medications subject to a shortage within VHA. Group‐based trajectory modeling was applied to users' monthly proportion of days covered (PDC) values from 6‐months before to 6‐months after the reported drug supply chain disruption. Patient demographics and medication characteristics were compared between identified trajectory groups using multivariable logistic regression.

Results

Among 1.5 million episodes of medication use (representing 1.3 million unique Veterans) for 29 medications in shortage in VHA, 6.3% were for female patients and the mean age was 66.4 ± 12.8 years. A 4‐group trajectory model had the best fit: High Adherence (69.2% of observations), Moderate Adherence (14.1%), Potential Shortage‐Related Disruption (8.5%), and Pre‐Shortage Disruption (8.3%). Drug characteristics (drug class, number of manufacturers) were more strongly associated than patient characteristics with having Potential Shortage‐Related Treatment Disruption vs. High Adherence.

Conclusions

We identified 4 trajectories of refill adherence for medications subject to VHA drug shortages, with 8.5% of users of affected drugs exhibiting a trajectory consistent with shortage‐related treatment disruption. Drug characteristics may modify whether drug shortages lead to treatment disruption in VHA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VeteransDrug MonitoringPrescription DrugsHumansUnited StatesFemaleRetrospective StudiesUnited States Department of Veterans AffairsAgedMaleChronic DiseaseMiddle AgedOutpatientsElectronic Health RecordsAmbulatory Care

Stichwörter der Autor:innen

drug shortagedrug supply chainmedication adherencetreatment disruptionveteran

Substanzen

Prescription Drugs

Autor:innen und Institutionen

  • Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.
  • Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • VA Center for Medication Safety/Pharmacy Benefits Management Services, Hines, Illinois, USA.
  • School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Pediatrics, Division of General Academic Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • VA Pharmacy Benefits Management Services, Washington, DC, USA.

ORCID-Profile: Sherrie L Aspinall, Taylor L Boyer, Walid F Gellad, Chester B Good, Mina Tadrous

Förderung

  • HSRD VA
  • U.S. Department of Veterans Affairs

Zitieren

APA

Suda, K. J., Zhao, X., Aspinall, S. L., Li, Y., Callaway Kim, K., Cunningham, F. E., Boyer, T. L., Miner, T. W., Kima, C., Gellad, W. F., Glassman, P. A., Good, C. B., Skelton, F., Tadrous, M., & Thorpe, C. T. (2026). Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages. Pharmacoepidemiology and Drug Safety, 35(6). https://doi.org/10.1002/pds.70393

Vancouver

Suda KJ, Zhao X, Aspinall SL, Li Y, Callaway Kim K, Cunningham FE, et al. Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages. Pharmacoepidemiology and Drug Safety. 2026;35(6). doi:10.1002/pds.70393

BibTeX
@article{Suda2026,
  author = {Suda, Katie J and Zhao, Xinhua and Aspinall, Sherrie L and Li, Yaming and Callaway Kim, Katherine and Cunningham, Francesca E and Boyer, Taylor L and Miner, Tate W and Kima, Clara and Gellad, Walid F and Glassman, Peter A and Good, Chester B and Skelton, Felicia and Tadrous, Mina and Thorpe, Carolyn T},
  title = {Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  volume = {35},
  number = {6},
  doi = {10.1002/pds.70393}
}
Kostenlos starten →